Brain metastasis in hypernephroma

• Published in: Journal of neuro-oncology 1987-01, Vol.5 (1), p.51-56
• Main Authors: Gay, P C, Litchy, W J, Cascino, T L
• Format: Article
• Language: English
• Subjects: Adult; Aged; Aged, 80 and over; Brain - diagnostic imaging; Brain Neoplasms - mortality; Brain Neoplasms - secondary; Brain Neoplasms - therapy; Carcinoma, Renal Cell - mortality; Carcinoma, Renal Cell - secondary; Carcinoma, Renal Cell - therapy; Female; Humans; Kidney Neoplasms - pathology; Male; Middle Aged; Tomography, X-Ray Computed
• ISSN: 0167-594X; 1573-7373
• DOI: 10.1007/BF00162765

Of 926 patients with hypernephroma, 36 (3.9%) had metastasis to the brain. The median age at presentation was 61 years (range, 34 to 82). Nineteen patients had a single lesion metastatic to the brain, and 16 of these lesions were supratentorial. In 28% of the patients, computed tomography showed hyperdense lesions before contrast material was injected. All patients, except 2 with incomplete records, had evidence of widespread disease involving bone, liver, or lung. The median time interval between the initial diagnosis and the discovery of brain metastasis was 65.5 weeks (range, 0 to 462), with only 2 patients initially presenting with brain metastasis. Twenty-five of the patients who received only radiation therapy had a median survival of 13 weeks (range, 4 to 146), while 7 selected patients who underwent surgical resection and postoperative radiation had a median survival of 66 weeks (range, 18 to 260). In 5 of the 7 patients, scans demonstrated recurrent tumor from 6 to 23 weeks postoperatively. One patient had a pronounced reduction in the size of the tumor after radiation therapy only. This study shows that brain metastasis is usually a late complication of hypernephroma and is associated with a poor prognosis.